Q4 2019 Ocular Therapeutix, Inc. Earnings Conference Call
Thursday, March 12, 2020 4:30 PM EDT
Ocular Therapeutix, Inc. at the Cowen and Company 40th Annual Health Care Conference
Tuesday, March 03, 2020 9:20 AM EST

Corporate Profile

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Our product pipeline candidates utilize the hydrogel technology to provide differentiated drug delivery solutions that are designed to reduce the complexity and burden of current drop or injection regimens by creati
(Common Stock)

Copyright West LLC. Minimum 15 minutes delayed.